South Dakota Investment Council Has $1,013,000 Stake in Cardinal Health, Inc. (CAH)
South Dakota Investment Council held its stake in Cardinal Health, Inc. (NYSE:CAH) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,000 shares of the company’s stock at the end of the 2nd quarter. South Dakota Investment Council’s holdings in Cardinal Health were worth $1,013,000 as of its most recent SEC filing.
Other large investors have also modified their holdings of the company. Bronfman E.L. Rothschild L.P. boosted its stake in Cardinal Health by 31.8% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 1,583 shares of the company’s stock worth $123,000 after purchasing an additional 382 shares during the period. JFS Wealth Advisors LLC boosted its stake in Cardinal Health by 14.3% during the 2nd quarter. JFS Wealth Advisors LLC now owns 1,949 shares of the company’s stock worth $152,000 after purchasing an additional 244 shares during the period. Dupont Capital Management Corp acquired a new stake in Cardinal Health during the 2nd quarter worth $164,000. First Personal Financial Services boosted its stake in Cardinal Health by 127.5% during the 2nd quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock worth $172,000 after purchasing an additional 1,238 shares during the period. Finally, Alpha Windward LLC boosted its stake in Cardinal Health by 0.7% during the 2nd quarter. Alpha Windward LLC now owns 2,299 shares of the company’s stock worth $179,000 after purchasing an additional 17 shares during the period. Hedge funds and other institutional investors own 87.68% of the company’s stock.
Shares of Cardinal Health, Inc. (CAH) opened at 69.29 on Thursday. Cardinal Health, Inc. has a one year low of $62.70 and a one year high of $84.88. The firm has a 50-day moving average of $69.10 and a 200-day moving average of $75.25. The firm has a market capitalization of $21.93 billion, a P/E ratio of 17.19 and a beta of 0.85.
Cardinal Health (NYSE:CAH) last announced its earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.24 by $0.07. The company had revenue of $32.97 billion during the quarter, compared to analyst estimates of $32.73 billion. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. The firm’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same period last year, the company posted $1.14 earnings per share. On average, equities analysts predict that Cardinal Health, Inc. will post $4.96 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Sunday, October 15th. Investors of record on Monday, October 2nd will be issued a $0.4624 dividend. This represents a $1.85 annualized dividend and a yield of 2.67%. The ex-dividend date of this dividend is Friday, September 29th. Cardinal Health’s dividend payout ratio is 45.79%.
WARNING: This report was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/09/14/south-dakota-investment-council-has-1013000-stake-in-cardinal-health-inc-cah.html.
A number of analysts recently weighed in on CAH shares. BidaskClub cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 11th. Vetr upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and set a $77.92 price target for the company in a research note on Tuesday, June 13th. ValuEngine cut shares of Cardinal Health from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Jefferies Group LLC started coverage on shares of Cardinal Health in a research note on Wednesday, May 17th. They set a “hold” rating and a $77.00 price target for the company. Finally, Zacks Investment Research upgraded shares of Cardinal Health from a “strong sell” rating to a “hold” rating in a research note on Tuesday, June 20th. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have given a buy rating to the stock. Cardinal Health has a consensus rating of “Hold” and an average target price of $79.58.
Cardinal Health Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Stock Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related stocks with our FREE daily email newsletter.